Profusa, Inc. (PFSA) stock
PFSANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NVACW
$0.35+0.01 (+1.84%)
Close on Nov 18, 2026Market cap $46.89KP/E –Yield –
Profusa net income
Net income is the profit left for shareholders after every expense, interest and tax.
Profusa's net income for the twelve months ending Jun 30, 2026 was -$42.97M. For fiscal 2025 it was -$35.82M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$35.82M | – |
| FY2024 | Dec 31, 2024 | -$9.23M | -894.4% |
| FY2023 | Dec 31, 2023 | $1.16M | -83.8% |
| FY2022 | Dec 31, 2022 | $7.17M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.76M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.46M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.57M | – |
| Q3 FY2025 | Sep 30, 2025 | -$22.19M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.35M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.72M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.25M | -1054.4% |
| Q3 FY2024 | Sep 30, 2024 | -$2.50M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.41M | -382.7% |
| Q1 FY2024 | Mar 31, 2024 | -$2.07M | -569.7% |
| Q4 FY2023 | Dec 31, 2023 | $235.97K | -51.1% |
| Q3 FY2023 | Sep 30, 2023 | -$367.35K | -120.8% |
| Q2 FY2023 | Jun 30, 2023 | $852.39K | -29.7% |
| Q1 FY2023 | Mar 31, 2023 | $440.90K | -88.1% |
| Q4 FY2022 | Dec 31, 2022 | $482.55K | – |
| Q3 FY2022 | Sep 30, 2022 | $1.76M | – |
| Q2 FY2022 | Jun 30, 2022 | $1.21M | – |
| Q1 FY2022 | Mar 31, 2022 | $3.71M | – |
See a number that looks wrong?